Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 390

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Activation of the type I interferon system in primary Sjögren's syndrome: A possible etiopathogenic mechanism

Båve, Ullvi, Nordmark, Gunnel, Lövgren, Tanja, Rönnelid, Johan, Cajander, Stefan, Eloranta, Maija‐Leena, Alm, Gunnar V., Rönnblom, Lars·2005·Arthritis & Rheumatism

Abstract

Objective: The etiopathogenesis of primary Sjögren's syndrome (SS) is largely unknown. In other autoimmune diseases, type I interferon (IFN) may play a pivotal role by triggering and sustaining the disease process. We therefore aimed to determine whether patients with primary SS had an activated type I IFN system. Methods: Salivary gland biopsy specimens and sera from patients with primary SS were investigated for the occurrence of IFNα‐producing cells and measurable IFNα levels, respectively. The ability of primary SS sera together with apoptotic or necrotic cells to induce IFNα production in normal peripheral blood mononuclear cells was examined. The IFNα inducer was characterized, and IFNα‐producing cells were identified. Clinical data were correlated with the IFNα‐inducing capacity of primary SS sera. Results: Numerous IFNα‐producing cells were detected in salivary gland biopsy specimens, despite low serum IFNα levels. Autoantibodies to RNA‐binding proteins, combined with material released by necrotic or late apoptotic cells, were potent inducers of IFNα production in plasmacytoid dendritic cells (PDCs). This appeared to be attributable to RNA‐containing immune complexes triggering PDCs by means of RNA and interaction with Fcγ receptor IIa. The IFNα‐inducing capacity of sera was associated with positive results of a labial salivary gland biopsy (focus score ≥1) and with dermatologic, hematologic, and pulmonary manifestations. Conclusion: Patients with primary SS have an activated type I IFN system. Although virus may initiate the production of IFN, the continued IFNα synthesis is caused by RNA‐containing immune complexes that activate PDCs to prolong IFNα production at the tissue level. This IFNα promotes the autoimmune process by a vicious circle–like mechanism, with increased autoantibody production and formation of more endogenous IFNα inducers.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/art.20998

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 44 references

Cited by

See all 390

Metadata

Authors
Båve, U., Nordmark, G., Lövgren, T., Rönnelid, J., Cajander, S., Eloranta, M., Alm, G. V., & Rönnblom, L.
Venue
Arthritis & Rheumatism
Publisher
Wiley
Published
2005-04
Volume
52
Issue
4
Pages
1185-1195
ISSN
  • 0004-3591 (ISSN-L)
  • 1529-0131
OpenAlex
W2071830659
Cited by
390
References
44
FWCI
14.05
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Activation of the type I interferon system in primary Sjögren's syndrome: A possible etiopathogenic mechanism. https://app.cochat.ai/papers/10.1002/art.20998
The paper
Båve, U., Nordmark, G., Lövgren, T., Rönnelid, J., Cajander, S., Eloranta, M., Alm, G. V., & Rönnblom, L. (2005). Activation of the type I interferon system in primary Sjögren's syndrome: A possible etiopathogenic mechanism. Arthritis & Rheumatism. https://doi.org/10.1002/art.20998

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.